It has been a week of mixed signals for Constellation Energy (Nasdaq: CEG), the nation’s largest nuclear power operator. A string of setbacks — regulatory delays, a major asset sale, a director departure, and a price target cut — weighed on shares even as analysts maintained an overwhelmingly bullish long-term outlook on the Baltimore-based company.
CEG ended the week trading around $303, well off its 52-week high of $412.70, leaving shareholders to weigh a stock that has pulled back sharply from its peak against a Wall Street consensus that still sees significant upside ahead.
A Nuclear Plant Delay Rattles Investors
The most market-moving headline of the week came Thursday, when Reuters reported that PJM Interconnection — the regional grid operator that oversees electricity transmission across much of the Eastern U.S. — informed Constellation that one of its nuclear plants would not be able to connect to the grid until 2031. The news was a blow to investors who had been counting on the restart timeline as a near-term catalyst, and it reinforced concerns about the slow pace of grid interconnection that has frustrated the broader energy industry.
A $5 Billion Asset Sale and What It Means
Adding to the week’s complexity, Constellation completed a significant divestiture, selling approximately 4.4 gigawatts of natural gas generating assets to LS Power for roughly $5 billion. The sale was a condition of regulators approving Constellation’s landmark acquisition of Calpine, which closed in January and made Constellation the largest electricity producer in the United States. While the deal demonstrates the company’s commitment to satisfying regulatory requirements, the 10.9% single-day decline the stock suffered in the wake of the announcement last week has continued to weigh on sentiment.
Governance Shake-Up
A director resignation this week added another wrinkle to an already eventful stretch. The departure triggered a governance change at the company, which is simultaneously navigating the integration of Calpine, a major shelf registration of up to 50 million common shares for an employee stock ownership plan, and a proxy filing urging shareholders to vote against a DEI-related proposal. For investors focused on corporate governance, it was a busy week to keep track of.
Morgan Stanley Provides a Boost Mid-Week
Not all of the week’s news was gloomy. On Wednesday, Morgan Stanley’s David Arcaro resumed coverage of Constellation with an overweight rating and a $385 price target — roughly 27% above where the stock was trading at the time. Arcaro highlighted Constellation’s position as the operator of the largest nuclear fleet in the U.S. as central to his thesis, noting that the Trump administration’s enthusiasm for nuclear power and the surging energy demands of artificial intelligence data centers make Constellation uniquely well-positioned among utilities.
The market responded positively, with shares rising about 3% on the day — a welcome reprieve in an otherwise difficult stretch.
Bank of America also weighed in, trimming its price target slightly to $401 from $407, while maintaining a bullish stance. The modest cut reflected near-term headwinds rather than any fundamental change in the long-term story.
The Bull Case Remains Intact
Despite the week’s turbulence, the broader investment thesis around Constellation remains largely unchanged on Wall Street. The company recently signed a 380-megawatt power agreement with data center giant CyrusOne adjacent to its Freestone Energy Center in Texas, with an exclusive option for an additional 380-megawatt Phase 2 — part of a growing portfolio of corporate power purchase agreements that now exceeds 1,100 megawatts contracted in Texas alone. The company has also secured 20-year license renewals from the Nuclear Regulatory Commission for its Clinton and Dresden plants, extending their operating lives well into the next decade.
Analysts project revenue of $26.7 billion and earnings of $3.6 billion by 2028. The average analyst price target sits at roughly $400, implying more than 30% upside from current levels, and all 16 analysts tracking the stock carry a buy-equivalent rating with zero sell recommendations.
The Bottom Line
Constellation Energy is a company in the middle of an enormous transformation — integrating a major acquisition, divesting assets to satisfy regulators, restarting nuclear plants, and locking in long-term contracts with AI-hungry tech giants. That kind of complexity rarely makes for smooth sailing in the short term, and this week was a reminder of that. But for investors with a longer time horizon, the underlying story — America’s largest nuclear fleet at the center of an AI-driven electricity supercycle — remains one of the most compelling in the utility sector.